Deals

Gilead Adds “Cornerstone” Cancer Drug in $21B Immunomedics Buyout

Gilead Adds “Cornerstone” Cancer Drug in $21B Immunomedics Buyout

9 days ago   |   Xconomy

Gilead Sciences is acquiring Immunomedics in a $21 billion deal, the latest in a string of transactions the company has made to bolster its cancer drug portfolio. The...
Read more ...

Satsuma Pharma's Migraine Drug Fails to Beat Placebo in Phase 3 Test

Satsuma Pharma's Migraine Drug Fails to Beat Placebo in Phase 3 Test

13 days ago   |   Xconomy   |   2 articles

An experimental Satsuma Pharmaceuticals treatment for acute migraine has failed a late-stage clinical trial, dealing a setback to the company's plans to offer another...
Read more ...

Grifols Moves Deeper Into Proteome R&D With $146M Deal for Alkahest

Grifols Moves Deeper Into Proteome R&D With $146M Deal for Alkahest

15 days ago   |   Xconomy

Alkahest, a company that analyzes blood proteins to develop therapies that address neurological disorders including Alzheimer's disease, is set to be acquired by partner...
Read more ...

AbbVie Strikes Deal for I-Mab Drug With a Potential Edge in CD47 Chase

AbbVie Strikes Deal for I-Mab Drug With a Potential Edge in CD47 Chase

18 days ago   |   Xconomy   |   2 articles

The cancer protein CD47 is a hot target for drug developers, but it's not without issues. Antibody drugs that block this protein can also spark anemia. I-Mab designed its...
Read more ...

Bio Roundup: Pharma M&A, AbbVie's Cancer Bet, Biofourmis Bucks & More

Bio Roundup: Pharma M&A, AbbVie's Cancer Bet, Biofourmis Bucks & More

19 days ago   |   Xconomy

Labor Day is just around the corner and many people are looking forward to a last chance to celebrate the waning days of summer. But ahead of the holiday weekend...
Read more ...

COVID-19 calls for virtue ethics

19 days ago   |   Oxford Journals

AbstractThe global spread of severe acute respiratory syndrome coronavirus 2 or coronavirus disease 19 has led to the imposition of severely restrictive measures by governments...
Read more ...

Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally

Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally

19 days ago   |   Xconomy

Biofourmis, a digital therapeutics startup that employs wearable devices and data analytics to help treat patients, has raised $100 million to scale its offerings globally and...
Read more ...

J&J, free from rival bidders, made Momenta wait on $6.5B deal

20 days ago   |   Fierce Biotech

J&J, free from rival bidders, made Momenta wait on $6.5B deal ntaylor Thu, 09/03/2020 - 08:49
Read more ...

Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs

Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs

20 days ago   |   Xconomy

If Lumen Bioscience achieves its goals, patients will be able to take its drugs the same way some people supplement breakfast: a spoonful heaped onto a bowl of cereal or mixed...
Read more ...

Santhera bags DMD drug in 3-way deal with Idorsia and ReveraGen

21 days ago   |   Fierce Biotech   |   2 articles

Santhera bags DMD drug in 3-way deal with Idorsia and ReveraGen ntaylor Wed, 09/02/2020 - 08:48
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Berkeley Team Plays Key Role in Analysis of Particle Interactions That...

Berkeley Team Plays Key Role in Analysis of Particle Interactions That Produce Matter From Light

This image shows a reconstruction of a particle event at CERN's ATLAS detector that produced W bosons from photons, which are particles of light. Researchers at the U.S... Read more ...

Tau-Targeting Alzheimer's Drug from AC Immune, Roche Fails in Phase 2

Tau-Targeting Alzheimer's Drug from AC Immune, Roche Fails in Phase 2

An Alzheimer's disease drug from partners AC Immune and Roche has failed a mid-stage clinical trial, adding another compound to the list of experimental therapies that have... Read more ...

Athira CEO Kawas: Alzheimer's Drug Aims for “Recovery of Brain Function”

Athira CEO Kawas: Alzheimer's Drug Aims for “Recovery of Brain Function”

The key to Athira Pharma's approach to Alzheimer's disease is already inside each of us: a repair mechanism that can regenerate damaged neurons. What's needed to begin the... Read more ...

Gene Therapy Firms Seek Clarity on FDA Exclusivity, Orphan Designations

Gene Therapy Firms Seek Clarity on FDA Exclusivity, Orphan Designations

Gene therapy product developers are seeking more clarity from the US Food and Drug Administration on when viral vectors from the same class will be considered sufficiently... Read more ...

Checkmate, Chromosome 8: The First End-to-End Sequence of a Human Autosome

Checkmate, Chromosome 8: The First End-to-End Sequence of a Human Autosome

Even in the field of genomics where new breakthroughs occur every few months, completion of the first-ever fully sequenced human autosome is a momentous achievement. Highly... Read more ...

Senior Analyst/Programmer II - Remote Role

The primary responsibilities of this position will be to lead database or statistical programming activities and provide end to end programming support in planning, specifying... Read more ...

Knockoff Boosted Tree for Model-Free Variable Selection

AbstractMotivationThe recently proposed knockoff filter is a general framework for controlling the false discovery rate when performing variable selection. This powerful new... Read more ...

IsoResolve: Predicting Splice Isoform Functions by Integrating Gene and...

AbstractMotivationHigh resolution annotation of gene functions is a central goal in functional genomics. A single gene may produce multiple isoforms with different functions... Read more ...

Bedtk: Finding Interval Overlap with Implicit Interval Tree

AbstractSummaryWe present bedtk, a new toolkit for manipulating genomic intervals in the BED format. It supports sorting, merging, intersection, subtraction and the calculation... Read more ...

Prioritizing transcriptomic and epigenomic experiments by using an...

AbstractMotivationSuccessful science often involves not only performing experiments well, but also choosing well among many possible experiments. In a hypothesis generation... Read more ...